Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
06/2009
06/09/2009US7544807 Ionic liquids
06/02/2009CA2344290C Quinazoline derivatives
05/2009
05/27/2009EP1404666B1 4-substituted-picolinic acid amide derivatives useful as fungicides
05/27/2009CN100491358C Pyrimidinone compounds, compositions and methods
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
05/26/2009CA2354774C Farnesyl protein transferase inhibitors
05/21/2009US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/21/2009US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
05/20/2009EP2060575A1 Dihydrothienopyrimidines and their use in treating inflammatory diseases
05/20/2009CN100488952C 5-phenyl pyridine, its preparation method and intermediate product and uses in controlling harmful fungus
05/19/2009CA2468879C Substituted cyclohexane derivatives
05/19/2009CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
05/12/2009US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
05/12/2009CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
05/06/2009EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
04/2009
04/30/2009US20090111862 Compound
04/28/2009USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma
04/22/2009EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors
04/22/2009EP1592389B1 Piperazine-2-carboxamide derivatives
04/22/2009CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents
04/21/2009US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
04/08/2009CN100475816C Reverse-turn mimetics and method relating thereto
04/08/2009CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
04/07/2009US7514475 Benzylamine analogues
04/07/2009CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
04/07/2009CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009US20090085006 Activators for oligonucleotide synthesis
04/01/2009CN100473669C Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
04/01/2009CN100473648C 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
03/2009
03/26/2009US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
03/24/2009US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor
03/24/2009CA2422380C Pyrazole compounds useful as protein kinase inhibitors
03/19/2009US20090076088 Thrombin Receptor Antagonists
03/18/2009EP1386912B1 Cyclic amidine derivative
03/18/2009EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
03/17/2009US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
03/17/2009US7504416 4-substituted quinolines as antitumor agents
03/17/2009US7504393 Benzylamine analogues
03/17/2009CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
03/12/2009US20090069383 Thrombin Receptor Antagonists
03/12/2009US20090068364 Method of surface treatment using imidazole compound
03/11/2009EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
03/11/2009EP1358165B1 Imidazole derivatives
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/10/2009US7501522 1-ethyl-3-methylimidazolium chloride mixed with potassium tert-butoxide forming 1-ethyl-3-methylimidazol-2-ylidene, which has been distilled off is brought into contact in the gaseous state with the protic acid
03/10/2009US7501505 1,1-Dioxo-1,2-dihydro-1 lambda 6-benzo[d]isothiazol-3-one will promote condensation of a nucleoside phosphoramidite and nucleoside monomer or a nascent oligonucleotide; genetic disorder diagnosis; gene expression inhibitors; treating cytomegalo virus; industrial scale
03/03/2009US7498343 Mycobacterial inhibitors
03/03/2009US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
03/03/2009CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
02/2009
02/26/2009US20090054459 Substituted indoles
02/25/2009EP2027132A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
02/24/2009US7495110 Benzimidazole derivatives and their use as GnRH antagonists
02/24/2009US7495021 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
02/24/2009CA2417361C New phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines
02/24/2009CA2336657C Method for producing carbonyl diimidazoles
02/24/2009CA2225416C A triazolylmethyl-indole ethylamine bisulfate salt
02/17/2009US7491748 e.g. (1) 3-(2-((naphthalen-1-ylmethyl)carbamoyl)-4-(2-methylphenoxymethyl)phenyl)propanoic acid; prostaglandin (PGE2) receptor ligand; analgesic, anticarcinogenic agent, antiallergen; neurodegenerative diseases
02/17/2009CA2317691C Triazole derivatives having antifungal activity
02/10/2009US7488742 Therapy for thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
02/10/2009US7488727 Thiazole compounds useful as inhibitors of protein kinase
02/10/2009CA2189044C Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
02/05/2009US20090036718 Use of a composition of an ionic nature as a substitution reagent, a composition constituting a fluorination reagent and a method using same
01/2009
01/29/2009US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
01/29/2009DE10038747B4 Verfahren zur Reinigung von Alkenylverbindungen A process for purifying alkenyl
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101353313A Process to produce oxazolidinones
01/27/2009US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis
01/27/2009US7482343 Mitotic kinesin KSP inhibitors; antiproliferative agents; 2-methylpyrimidin-4-ones
01/27/2009CA2346796C Benzoylcyclohexanediones, process for their preparation and their use as herbicides and plant growth regulators
01/27/2009CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
01/20/2009US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis
01/20/2009US7479495 N-heterocyclic inhibitors of TNF-α expression
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/14/2009EP2014285A1 NPYY5 antagonists
01/14/2009EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors
01/14/2009EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
01/13/2009US7476688 Cyclic amidine derivatives
01/13/2009US7476682 N-substituted piperidine derivatives as serotonin receptor agents
01/07/2009EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
01/07/2009EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents
01/07/2009EP1001939B1 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
01/06/2009US7473699 antibiotic; Gram-positive pathogens (Staphylococci, Enterococci, and Streptococci ), MRSA and MRCNS; resistance to vancomycin and E. faecium to both aminoglycosides and beta--lactams; gram negative strains H.influenzae, M.catarrhalis and chlamydia; improved activity against mono-amine oxidase (MAO)
01/06/2009US7473691 Pyrazole compounds useful as protein kinase inhibitors
12/2008
12/31/2008EP1654254A4 Antifungal azole derivatives having a fluorovinyl moiety and process for the preparation thereof
12/31/2008EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound
12/31/2008CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/17/2008CN100443481C Imidazolyl-cyclic acetals
12/16/2008US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases
12/16/2008CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/10/2008EP1999121A1 Novel tetralins as 5-ht6 modulators
12/10/2008CN100441556C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/09/2008CA2337804C Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/02/2008US7459561 Containing pyridine, phenyl, thiazole and triazole rings, e.g., 1-[[N-methyl-N-3-[(methylamino)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,4-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl ]butyl]-1H-[1,2,4]triazol-4-ium chloride; parenteral treatment of fungal diseases
11/2008
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 163